| Income Statement |
| Total Revenue | 6.59M |
|
| Revenues (USD) | 6.59M |
| Cost of Revenue | 4.79M |
| Gross Profit | 1.80M |
| Operating Expenses | 4.79M |
| Research and Development Expense | 623.00K |
| Selling, General and Administrative Expense | 4.17M |
| Operating Income | -2.99M |
| Interest Expense | 184.00K |
| Net Income | -3.17M |
| Net Income Common Stock | -3.17M |
| Net Income Common Stock (USD) | -3.17M |
| Consolidated Income | -3.17M |
| Earnings per Basic Share | -0.15 |
| Earnings per Basic Share (USD) | -0.15 |
| Earnings per Diluted Share | -0.15 |
| Earning Before Interest & Taxes (EBIT) | -2.99M |
| Earning Before Interest & Taxes (USD) | -2.99M |
| Weighted Average Shares | 21.34M |
| Weighted Average Shares Diluted | 21.34M |
| Balance Sheet |
| Cash and Equivalents | 372.00K |
| Cash and Equivalents (USD) | 372.00K |
| Trade and Non-Trade Receivables | 3.86M |
| Current Assets | 23.43M |
| Property, Plant & Equipment Net | 2.08M |
| Total Assets | 25.60M |
| Debt Current | 6.43M |
| Total Debt | 6.54M |
| Current Liabilities | 20.59M |
| Debt Non-Current | 105.00K |
| Total Liabilities | 20.99M |
| Accumulated Retained Earnings (Deficit) | -111.52M |
| Shareholders Equity | 4.61M |
| Shareholders Equity (USD) | 4.61M |
| Assets Non-Current | 2.17M |
| Total Debt (USD) | 6.54M |
| Deferred Revenue | 434.00K |
| Deposit Liabilities | 62.00K |
| Inventory | 16.66M |
| Liabilities Non-Current | 397.00K |
| Trade and Non-Trade Payables | 8.27M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 433.00K |
| Net Cash Flow from Financing | 955.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -556.00K |
| Capital Expenditure | -120.00K |
| Issuance (Purchase) of Equity Shares | 3.85M |
| Issuance (Repayment) of Debt Securities | 943.00K |
| Net Cash Flow from Investing | -120.00K |
| Net Cash Flow from Operations | -1.39M |
| Share Based Compensation | 240.00K |